Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Martin

Showing results (171-180 of 278) with videos related to

Pageof 28
Sort By:
NPJ Breast Cancer|April 26, 2024
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE studyMatthew P Goetz, Irfan Cicin, Laura Testa, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2022
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agentsVicente Escudero-Vilaplana, Roberto Collado-Borrell, Patricia Gómez Martínez-Sagrera, et al.
Clinical Breast Cancer|December 31, 2005
The global breast cancer burden: variations in epidemiology and survivalGabriel N Hortobagyi, Jaime de la Garza Salazar, Kathleen Pritchard, et al.
Clinical Breast Cancer|November 5, 2020
nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast CancerErika Hamilton, Javier Cortes, Ozgur Ozyilkan, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Intracellular Mechanosensation in Intestinal Smooth Muscle: Piezo1 Complexes Amplify Signaling Beyond the SurfaceGeoanna M Bautista, Declan Manning, Emily C Lieu, et al.
Obesity (Silver Spring, Md.)|April 25, 2009
Interplay between weight loss and gut microbiota composition in overweight adolescentsArlette Santacruz, Ascensión Marcos, Julia Wärnberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancerAngelo Di Leo, Guy Jerusalem, Lubos Petruzelka, et al.
The Lancet. Oncology|December 7, 2019
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trialRobert Coleman, Dianne M Finkelstein, Carlos Barrios, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancerEva Thomas, Josep Tabernero, Monica Fornier, et al.
The New England Journal of Medicine|December 14, 2016
Palbociclib and Letrozole in Advanced Breast CancerRichard S Finn, Miguel Martin, Hope S Rugo, et al.
Pageof 28

Showing results (171-180 of 278) with videos related to

Sort By:
Pageof 28
NPJ Breast Cancer|April 26, 2024
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE studyMatthew P Goetz, Irfan Cicin, Laura Testa, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2022
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agentsVicente Escudero-Vilaplana, Roberto Collado-Borrell, Patricia Gómez Martínez-Sagrera, et al.
Clinical Breast Cancer|December 31, 2005
The global breast cancer burden: variations in epidemiology and survivalGabriel N Hortobagyi, Jaime de la Garza Salazar, Kathleen Pritchard, et al.
Clinical Breast Cancer|November 5, 2020
nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast CancerErika Hamilton, Javier Cortes, Ozgur Ozyilkan, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Intracellular Mechanosensation in Intestinal Smooth Muscle: Piezo1 Complexes Amplify Signaling Beyond the SurfaceGeoanna M Bautista, Declan Manning, Emily C Lieu, et al.
Obesity (Silver Spring, Md.)|April 25, 2009
Interplay between weight loss and gut microbiota composition in overweight adolescentsArlette Santacruz, Ascensión Marcos, Julia Wärnberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancerAngelo Di Leo, Guy Jerusalem, Lubos Petruzelka, et al.
The Lancet. Oncology|December 7, 2019
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trialRobert Coleman, Dianne M Finkelstein, Carlos Barrios, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancerEva Thomas, Josep Tabernero, Monica Fornier, et al.
The New England Journal of Medicine|December 14, 2016
Palbociclib and Letrozole in Advanced Breast CancerRichard S Finn, Miguel Martin, Hope S Rugo, et al.
Pageof 28